text: The primary use of IMiDs in medicine is in the treatment of cancers and autoimmune diseases (including one that is a response to the infection leprosy). Indications for these agents that have received regulatory approval include:
  * Myelodysplastic syndrome, a precursor condition to acute myeloid leukaemia
  * Erythema nodosum, a complication of leprosy
  * Multiple myeloma
  Off-label indications for which they seem promising treatments include:
  * Hodgkin's lymphoma
  * Light chain-associated (AL) amyloidosis
  * Primary myelofibrosis (PMF)
  * Acute myeloid leukaemia (AML)
  * Prostate cancer
  * Metastatic renal cell carcinoma (mRCC)